Drug Trial Radar · NCT06422923
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Last checked: Nov 19, 2026Latest source record: Jan 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Nov 14, 2024
Primary completion
Jun 15, 2027
Study completion Jun 15, 2042
Sponsor
- Lead sponsor
- Neurona TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- May 21, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, single arm, open label clinical trial that is designed to test the safety and preliminary efficacy of single administration inhibitory nerve cells called interneurons (NRTX-1001), into both temporal lobes of subjects with drug-resistant bilateral mesial temporal lobe epilepsy.
Conditions
- Epilepsy, Temporal Lobe
Interventions
NRTX-1001Biological
Biological: NRTX-1001 is an inhibitory neural cell therapy investigational product. It is derived from a human stem cell line that has been converted into high-purity inhibitory interneurons that produce GABA. NRTX-1001 is intended to persist long-term and not require repeated administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Serious Adverse Events at end of month 12Time frame: 12 months after treatment
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
University of Arkansas for Medical Sciences
Little Rock, Arkansas · Recruiting
University of Southern California Keck Hospital
Los Angeles, California · Recruiting
UC Irvine Medical Center
Orange, California · Recruiting
Stanford University
Palo Alto, California · Recruiting
University of California San Diego
San Diego, California · Recruiting
University of California San Francisco
San Francisco, California · Withdrawn
University of Colorado Anschutz Medical Campus
Aurora, Colorado · Recruiting
University of Chicago
Chicago, Illinois · Recruiting
University of Iowa Health Care
Iowa City, Iowa · Recruiting
SUNY Upstate Medical University
Syracuse, New York · Recruiting
Atrium Health
Charlotte, North Carolina · Recruiting
Duke University Hospital
Durham, North Carolina · Recruiting
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina · Recruiting
Oregon Health and Science University
Portland, Oregon · Recruiting
UTHealth Houston
Houston, Texas · Recruiting
UVA Health University Medical Center
Charlottesville, Virginia · Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.